Literature DB >> 20808227

A novel approach to increase awareness about hereditary colon cancer using a state cancer registry.

Jan T Lowery1, Lisen Axell, Kieu Vu, Randi Rycroft.   

Abstract

PURPOSE: The aim of this project was to conduct educational outreach about hereditary colon cancer to a targeted high risk population identified through a state cancer registry.
METHODS: Individuals who met one of the first three Bethesda criteria guidelines were identified through the Colorado Central Cancer Registry. The physician of record received a brochure, survey and form to provide written consent to contact patient(s). Cases were mailed an educational brochure, initial and follow-up survey.
RESULTS: Five hundred seventy-five cases and 412 physicians were identified; 81% provided consent. Ninety percent of physicians felt the registry should provide this information to at-risk patients. Twenty-three percent of the cases returned the survey. Cases were generally glad to get the information. Only four cases reported concern. The majority agreed the cancer registry should send the information, however most preferred their physicians be consented first. At follow-up, 20 cases reported having or intending to have a risk assessment.
CONCLUSIONS: Response from physicians and cases was positive, suggesting that targeted outreach using cancer registries, in combination with physician notification, may be a viable approach to educational outreach about cancer genetics. A proportion of cases sought risk assessment, suggesting that mail-based outreach may be effective in increasing uptake of information and/or genetic services.

Entities:  

Mesh:

Year:  2010        PMID: 20808227     DOI: 10.1097/GIM.0b013e3181f1366a

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  6 in total

1.  Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.

Authors:  Anita Y Kinney; Laurie E Steffen; Barbara H Brumbach; Wendy Kohlmann; Ruofei Du; Ji-Hyun Lee; Amanda Gammon; Karin Butler; Saundra S Buys; Antoinette M Stroup; Rebecca A Campo; Kristina G Flores; Jeanne S Mandelblatt; Marc D Schwartz
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

2.  Are cancer registries a viable tool for cancer survivor outreach? A feasibility study.

Authors:  Melissa Y Carpentier; Jasmin A Tiro; Lara S Savas; L Kay Bartholomew; Trisha V Melhado; Sharon P Coan; Keith E Argenbright; Sally W Vernon
Journal:  J Cancer Surviv       Date:  2012-12-18       Impact factor: 4.442

Review 3.  Initiatives to Scale Up and Expand Reach of Cancer Genomic Services Outside of Specialty Clinical Settings: A Systematic Review.

Authors:  Yue Guan; Colleen M McBride; Hannah Rogers; Jingsong Zhao; Caitlin G Allen; Cam Escoffery
Journal:  Am J Prev Med       Date:  2020-11-07       Impact factor: 5.043

Review 4.  Perspectives on neurological patient registries: a literature review and focus group study.

Authors:  Lawrence Korngut; Gail MacKean; Lisa Casselman; Megan Johnston; Lundy Day; Darren Lam; Diane Lorenzetti; Janet Warner; Nathalie Jetté; Tamara Pringsheim
Journal:  BMC Med Res Methodol       Date:  2013-11-09       Impact factor: 4.615

5.  Improving Screening Uptake among Breast Cancer Survivors and Their First-Degree Relatives at Elevated Risk to Breast Cancer: Results and Implications of a Randomized Study in the State of Georgia.

Authors:  Joseph Lipscomb; Cam Escoffery; Theresa W Gillespie; S Jane Henley; Robert A Smith; Toni Chociemski; Lyn Almon; Renjian Jiang; Xi Sheng; Michael Goodman; Kevin C Ward
Journal:  Int J Environ Res Public Health       Date:  2020-02-04       Impact factor: 3.390

Review 6.  Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework.

Authors:  Ridgely Fisk Green; Mary Ari; Katherine Kolor; W David Dotson; Scott Bowen; Nancy Habarta; Juan L Rodriguez; Lisa C Richardson; Muin J Khoury
Journal:  Genet Med       Date:  2018-06-15       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.